LEADER 01392cam0-22004091i-450- 001 990006561070403321 005 20140725175303.0 035 $a000656107 035 $aFED01000656107 035 $a(Aleph)000656107FED01 035 $a000656107 100 $a20010426d1943----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $ay-------001yy 200 1 $aRelazioni degli ambasciatori veneti al senato$eserie 3. (secolo 18.)$fa cura di Ruggero Moscati$eFrancia 210 $aMilano$cIstituto per gli studi di politica internazionale$d1943 215 $aXVII, 221 p.$d27 cm 225 1 $aFonti per la storia d'Italia$fpubblicate dall'Istituto storico italiano per l'età moderna e contemporanea$v11 610 0 $aVenezia $aPolitica estera$aSec. 16.-17.$aFonti diplomatiche 610 0 $aAmbasciatori veneti$aRelazioni$aSec. 16.-18. 610 0 $aItalia$aStoria$aFonti 676 $a945.07$v21$zita 676 $a327 676 $a945.31 702 1$aMoscati,$bRuggero$f<1909-1981> 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990006561070403321 952 $aXI A 1811$b7655$fFSPBC 952 $aSE 091.05.12-$b015.164$fDECSE 952 $a945.07 ISI 6$bST.MED.MOD. 647$fFLFBC 959 $aFSPBC 959 $aFLFBC 959 $aDECSE 996 $aRelazioni degli ambasciatori veneti al Senato$976695 997 $aUNINA LEADER 04265nam 2200649Ia 450 001 9910145260003321 005 20170815105935.0 010 $a1-118-67350-6 010 $a1-282-34938-4 010 $a9786612349386 010 $a0-470-74134-1 035 $a(CKB)1000000000707370 035 $a(EBL)416371 035 $a(OCoLC)313862959 035 $a(SSID)ssj0000112506 035 $a(PQKBManifestationID)11129193 035 $a(PQKBTitleCode)TC0000112506 035 $a(PQKBWorkID)10097330 035 $a(PQKB)11102822 035 $a(MiAaPQ)EBC416371 035 $a(EXLCZ)991000000000707370 100 $a20080915d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aBiotechnology valuation$b[electronic resource] $ean introductory guide /$fKarl D. Keegan 210 $aChichester, England ;$aHoboken, NJ $cJohn Wiley & Sons$dc2008 215 $a1 online resource (220 p.) 225 1 $aWiley finance 300 $aDescription based upon print version of record. 311 $a0-470-51178-8 320 $aIncludes bibliographical references (p. [189]-192) and index. 327 $aBiotechnology Valuation; Contents; Acknowledgements; 1 Introduction; Biotechnology Background; 2 Traditional Valuation Methods; The Value of a Company; Accounts - Providing the Data for Valuation Analysis; The Income Statement; Balance Sheet; Cash Flow Statement; Income Statement Multiples; Balance Sheet Multiples; Summary; Discounted Cash Flow Analysis; Net Present Value; Constructing the DCF; Projecting the Cash Flow Stream; Choosing a Discount Rate; Other Thoughts; 3 The Drug Development Process; The Drug Development Process; Drug Discovery and Research; Pre-Clinical Development 327 $aClinical TrialsWhat Investors Should Look For When Analysing Clinical Trials; Conclusion; The Regulatory Process; Regulation in the US; Regulation in Europe; The Label; Timelines for Approval; Post Approval; Investment Lessons; Case Study #1; 4 Biotechnology Company Valuation; Data Collation; NPV of the Pipeline; Calculations; Sensitivity Analyses; DCF of Whole Company; EBIT DCF of Products; Comparables Valuation; NPVs are Additive; Using all the Tools Available to Reach a Valuation Conclusion; Market Models; Conclusion; Appendix 1; Example 1; Example 2; Example 3; Appendix 2 327 $aBiosimilar Update5 Decision Trees and Real Options; Decision Trees; Discount Rate; Deriving Scenarios; Conclusion; Decision Tree Example; Real Options; Valuing Options; Estimation of the Input Variables; Conclusions; 6 Biotechnology Investing; Types of Healthcare Investment; Biotechnology Sector Evolution; Biotechnology Investment Cycles; Biotechnology Business Models; Focus on People; Cash; Product Pipeline; Commercial Risks; Newsflow; Lessons from Biotech Investing; 7 Early-stage Valuation; Private Valuation; Discounted Cash Flow Method; Comparable Valuation; Venture Capital Method 327 $aDiscount RatesConclusion; Glossary; References; Index 330 $aThe first book to provide a simple and practical means of valuing biotech companiesThe book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dipsIt examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the USLooks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical 410 0$aWiley finance series. 606 $aBiotechnology industries$xValuation 606 $aPharmaceutical industry$xValuation 606 $aInvestment analysis 608 $aElectronic books. 615 0$aBiotechnology industries$xValuation. 615 0$aPharmaceutical industry$xValuation. 615 0$aInvestment analysis. 676 $a332.63221 676 $a380.1456606 700 $aKeegan$b Karl D$0911732 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910145260003321 996 $aBiotechnology valuation$92041697 997 $aUNINA LEADER 01755nam0 2200373 i 450 001 MIL0340982 005 20251003044231.0 010 $a8820323907$bHoepli 020 $aIT$b98-11810 100 $a20220527d1997 ||||0itac50 ba 101 | $aita 102 $ait 181 1$6z01$ai $bxxxe 182 1$6z01$an 183 1$6z01$anc$2RDAcarrier 200 1 $aCertificare la qualità$estrumenti, metodi, servizi per sistemi aziendali e prodotti$ele norme ISO 9000 verso la qualità totale$fa cura di Pierangelo Andreini 205 $a2. ed 210 $aMilano$cAnima$cHoepli$d\1997! 215 $a475 p.$d24 cm 300 $aSeguono appendici. 606 $aProdotti industriali$xControllo di qualità$xStandardizzazione$2FIR$3CFIC068280$9I 676 $a658.5$9GESTIONE GENERALE. GESTIONE DELLA PRODUZIONE$v14 676 $a658.5$9GESTIONE DELLA PRODUZIONE$v21 702 1$aAndreini$b, Pierangelo$3CFIV032952 801 3$aIT$bIT-000000$c20220527 850 $aIT-BN0095 $aIT-NA0079 901 $bNAP BN$cMAGAZZINO $nmagazzini correnti divisi per anni 901 $bNAP BN$cS.MOD $nLa consegna dei documenti è effettuata dall'Ufficio Distribuzione 901 $bNAP 01$cPOZZO LIB.$nVi sono collocati fondi di economia, periodici di ingegneria e scienze, periodici di economia e statistica e altri fondi comprendenti documenti di economia pervenuti in dono. 912 $aMIL0340982 950 0$aBiblioteca Centralizzata di Ateneo$b1 v.$c1 v.$d 01POZZO LIB.ECON MON 9694$e 0101 0000112355E VMA 1 v. (Precedente collocazione: GUERRAZZI B 198)$fB $h20090616$i20090616 977 $a 01$a BN 996 $aCertificare la qualità$965097 997 $aUNISANNIO